GlassScriptPhysician profile
Christopher Monpin Ma
NPI 1992123491
$528.53
in general payments reported to CMS, 2019-2025
10 companies · $220 in 2025
The $220 reported for 2025 was more than what 82% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.81 · 2023: $14.94 · 2024: $275 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $509.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $220.83 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System, Atriclip Laa Exclusion System |
| Medtronic, INC. | $93.32 | 2024-2025 | Bis, Mcgrath Mac, Invos |
| Becton, Dickinson and Company | $57.86 | 2024-2025 | Hemosphere |
| Grifols USA, LLC | $39.39 | 2025 | Thrombate III |
| Octapharma USA, INC. | $28.23 | 2025 | Fibryga |
| Chiesi USA, INC. | $20.60 | 2025 | Cleviprex |
| Merck Sharp & Dohme LLC | $18.81 | 2019 | |
| Eagle Pharmaceuticals, INC. | $18.32 | 2024 | |
| Fisher & Paykel Healthcare INC | $16.23 | 2025 | Fisher & Paykel Healthcare |
| Boston Scientific Corporation | $14.94 | 2023 | Avvigo Guidance System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.